<?xml version="1.0" encoding="UTF-8"?>
<p id="p0115">The reduction in melatonin production, as in elderly people or those with chronic metabolic diseases, induces insulin resistance, glucose intolerance, sleep disturbance, and metabolic circadian disorganization characterizing a state of chronodisruption leading to obesity (
 <xref rid="bib17" ref-type="bibr">Cipolla-Neto et al., 2014</xref>). These findings indicate that melatonin complementary therapy can play a vital role in reestablishing a more healthy condition of individuals with chronic metabolic diseases.
</p>
